Literature DB >> 2872563

Multiple mu opiate receptors.

G W Pasternak, P J Wood.   

Abstract

In addition to morphine-selective mu 2 and enkephalin-preferring delta sites, recent evidence supports the presence within the central nervous system of a common site with very high affinity for both enkephalins and opiates termed the mu 1 site. This concept of a common, very high affinity site for multiple neurotransmitters is a unique concept in neuropharmacology, differing from classical transmitter systems which possess multiple receptor classes for a single transmitter. This review will address both the biochemical and pharmacological evidence supporting the existence of this site.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2872563     DOI: 10.1016/0024-3205(86)90217-1

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  30 in total

1.  Blood-brain barrier transport and brain distribution of morphine-6-glucuronide in relation to the antinociceptive effect in rats--pharmacokinetic/pharmacodynamic modelling.

Authors:  M R Bouw; R Xie; K Tunblad; M Hammarlund-Udenaes
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

2.  Involvement of mu-opioid receptors in the antitussive effects of pentazocine.

Authors:  J Kamei; K Katsuma; Y Kasuya
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-02       Impact factor: 3.000

3.  Involvement of opioid receptor subtypes in both stimulatory and inhibitory effects of the opioid peptides on prolactin secretion during pregnancy.

Authors:  M Soaje; R P Deis
Journal:  Cell Mol Neurobiol       Date:  2004-04       Impact factor: 5.046

4.  Opiate receptors and the endorphin-mediated cardiovascular effects of clonidine in rats: evidence for hypertension-induced mu-subtype to delta-subtype changes.

Authors:  R Mosqueda-Garcia; G Kunos
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

5.  Endogenous monoamine analgesic systems: amitriptyline in painful diabetic neuropathy.

Authors:  M B Max
Journal:  Anesth Prog       Date:  1987-07

Review 6.  Opioids and exercise. An update.

Authors:  G A Sforzo
Journal:  Sports Med       Date:  1989-02       Impact factor: 11.136

7.  Mechanisms of inhibitory action of TRK-130 (Naltalimide), a μ-opioid receptor partial agonist, on the micturition reflex.

Authors:  Morihiro Fujimura; Naoki Izumimoto; Sayoko Kanie; Ryosuke Kobayashi; Satoru Yoshikawa; Shinobu Momen; Mikito Hirakata; Toshikazu Komagata; Satoshi Okanishi; Masashi Iwata; Tadatoshi Hashimoto; Takayuki Doi; Naoki Yoshimura; Koji Kawai
Journal:  Int Urol Nephrol       Date:  2017-01-16       Impact factor: 2.370

8.  Cholecystokinin as a factor in the enhanced potency of spinal morphine following carrageenin inflammation.

Authors:  L C Stanfa; A H Dickenson
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

9.  Variation in tolerance to the antinociceptive, hormonal and thermal effects of morphine after a 5-day pre-treatment of male rats with increasing doses of morphine.

Authors:  P T Männistö; S A Borisenko; P Rauhala; P Tuomainen; R K Tuominen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-02       Impact factor: 3.000

10.  mu opiate receptor: cDNA cloning and expression.

Authors:  J B Wang; Y Imai; C M Eppler; P Gregor; C E Spivak; G R Uhl
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.